Related by context. Frequent words. (Click for all words.) 63 inflammatory autoimmune diseases 63 Medarex logo 63 Eligard R 61 visit www.PAREXEL.com 61 By Thomas Gryta 61 Eligard ® 60 R sorafenib tablets 60 Entereg R 60 MGCD# MGCD# [001] 60 Rosetta dependence 60 unique PER.C6 ® 59 BioMarin Genzyme LLC 59 UltiMAb R technology 59 based pretargeting methods 59 FACTIVE R gemifloxacin 59 Alnylam dependence 59 Takeda Kyowa Hakko Kirin 59 interferon gamma 1b 59 By Priyanka Dayal 59 ® bortezomib 59 vernakalant oral 58 TELINTRA 58 SANCTURA R 58 obj obj = 58 BioGlue R 58 THALOMID 58 http:/www.nicusa.com 57 By TheStreet Wire 57 TranSwitch indebtedness 57 NEBIDO R 57 functional genomics proteomics 57 non personalized allogeneic 57 gastrointestinal mucositis 57 neutropenia thrombocytopenia 57 leading lipid nanoparticle 57 MassARRAY R 57 2 methoxyestradiol 57 immunological disorders 57 including nutritionals devices 57 ZALBIN 57 www.nicusa.com 57 Panzem R 57 Taiho Pharmaceutical 56 low toxicity bioscience 56 please visit www.inhibitex.com 56 BioSante licensees 56 Shigamabs ® 56 Tissue Repair Company 56 chemotherapy induced neutropenia 56 Genentech Bayer CuraGen 56 affecting Amarin 56 HepeX B 56 Rotarix R 55 Tekturna Rasilez 55 http:/www.optimerpharma.com 55 Genitope Corporation 55 Johnnie Walker Guinness Smirnoff 55 Ethyol 55 commercialize telaprevir 55 Gemzar ® 55 vosaroxin 55 Currently RegeneRx 55 Advicor 55 viii insufficient 55 Antigen Express website 55 Asentar 55 Xyntha 55 FINANCIAL CONDITION AND 54 forodesine 54 forward.looking statements 54 menopause contraception 54 www.norsat.com 54 AMB invests 54 YOUR LOCAL ANIMAL SHELTER 54 Alferon N Injection 54 through ImmunoGen collaborations 54 party VLSI fabrication 54 Bioenvision compounds under 54 regarding Heska 54 AQ4N 54 elotuzumab 54 CPL Biologicals 54 SIRT1 activators 54 Surgical Adhesive 54 B Baileys Cuervo 53 NEUPOGEN 53 Argatroban 53 AnalogicTech logo 53 TOCOSOL Paclitaxel 53 Anturol 53 novel ZFP TFs 53 SILENOR TM 53 * Potentially libelous 53 Nasdaq CRXL 53 MGCD# MGCD# [002] 53 Prodarsan ® 53 successfully commercialize REOLYSIN 53 Adagen 53 Enablex 53 opioid induced bowel dysfunction 53 candidates bavituximab